Results 81 to 90 of about 37,818 (285)

Switching disease‐modifying therapies in patients with spinal muscular atrophy: A systematic review on effectiveness outcomes

British Journal of Clinical Pharmacology, EarlyView.
With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić, Elvira Meni Maria Gkrinia, Patrick Eustaquio, Andrea Katrin Faour, Dinko Vitezić   +4 more
wiley   +1 more source

In search of best practices for pricing and reimbursement of telemedicine services: A systematic review

, 2022
Telemedicine is the practice of caring for patients remotely with the support of technology. The World Health Organization (WHO) has emphasized that the use and scale of digital solutions “can revolutionize how people worldwide achieve higher standards ...
Peter Agyei-Baffour, Mary Efua Commeh
core   +1 more source

Trends in the utilization, expenditure and costs of noninsulin glucose‐lowering drugs in the Medicaid population: Steady increases in glucagon‐like peptide‐1 receptor agonist and sodium–glucose transporter‐2 inhibitor use, prices and expenditure

British Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to analyse changes in the utilization, expenditure and average cost of noninsulin glucose‐lowering drugs (GLDs) between 2008 and 2023. Methods This was a retrospective observational study of 2008–2023 data from the National Medicaid State Drug Utilization database.
Rawan O. Almadfaa
wiley   +1 more source

Retrospective or Prospective Reimbursement Systems: Evaluating the Efficiency of the Global Payment System in Public Hospitals in Bushehr Province [PDF]

Iranian South Medical Journal
Background: Reimbursement systems play an important role in controlling costs and improving hospital efficiency. This study aimed to compare the billing costs of procedures subject to global tariffs with the notified tariffs for the same procedures to ...
Habib Omranikhoo, Mohbubeh Shahbazifard, Mahdieh Ardaneh, Mahdi Rezaee   +3 more
doaj  

Acceptability to general practitioners of national health insurance and capitation as a reimbursement mechanism.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 1996
To determine general practitioners' attitudes to national health insurance (NHI) and to capitation as a mechanism of reimbursement. To explore determinants of these attitudes.Cross-sectional survey by means of telephone interviews; four focus group discussions.Cape Peninsula.174 GPs randomly sampled from a total population of 874.Acceptance of NHI ...
Blecher, M.S., Bachmann, M.O., McIntyre, D.   +2 more
openaire   +2 more sources

Optimization of pharmaceutical research and development by early‐phase assessment of investigational medicinal products

British Journal of Clinical Pharmacology, EarlyView.
Small and mid‐sized pharmaceutical innovators often have limited in‐house health economics and market access expertise, and may struggle to align development strategies of investigational medicinal products with health system needs and payer expectations.
Zoltán Kaló, Attila Imre, Gábor Varga, Sándor Kovács, György Tímár, Balázs Nagy   +5 more
wiley   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

„Pay-back” mechanism in the Polish reimbursement system - analysis and appraisal

Journal of Health Policy & Outcomes Research, 2014
The text of this review has been based on a diploma thesis, prepared by Mr Borys Podgorny under the supervision of Dr Iwona Skrzekowska-Baran, as part of the XXII Edition of the Advanced Management Training in Pharmacoeconomics, HTA, Pharma Marketing and Law of the Warsaw University Of Technology Business School.
openaire   +1 more source

Historical analysis of reimbursement mechanisms with a focus on outpatient care. [PDF]

Historická analýza úhradových mechanismu se zaměřením na ambulantní péči: Hlavním cílem diplomové práce je vyhodnocení účinnosti úhradového mechanismu v ambulantní péči. Analyzuje a porovnává očekávané a skutečné úhrady za ambulantní péči od pojišťoven v
Gabriela Angelová
core  

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source